Top-News
  • Depot
  • Watchlist
  • Glocke
  • Handeln

    • CytomX Therapeutics Inc. News

    1,53 € +2,00% +0,03 €
    30.04.24 22:58:40 L&S RT aktualisieren | Orderbuch | Mehr Kurse »
    WKN: A14158
    ISIN: US23284F1057
    US-Symbol: CTMX
    Typ: Aktie

    CytomX Therapeutics Inc. News

    17.01.23 - DerFinanzinvestor
    Übernahme und Absturz - CytomX, Defence Therapeutics, Moderna, Novavax
    Während Finanzminister Lindner wegen einer erheblichen Milliardenlücke im Bundeshaushalt durch massiv gestiegene Zinszahlungen den Ministerien nun erst ...
    06.01.23 - PR Newswire
    Thinking about buying stock in Spruce Biosciences, CytomX Therapeutics, Boxed, Mobile Global Esports, or Emergent Biosolutions?
    Thinking about buying stock in Spruce Biosciences, CytomX Therapeutics, Boxed, Mobile Global Esports, or Emergent Biosolutions? PR Newswire
    05.01.23 - PR Newswire
    Thinking about buying stock in Novocure, Zai Lab, Kala Pharmaceuticals, Orchard Therapeutics, or CytomX Therapeutics?
    Thinking about buying stock in Novocure, Zai Lab, Kala Pharmaceuticals, Orchard Therapeutics, or CytomX Therapeutics? PR Newswire
    17.11.22 - PR Newswire
    Regeneron and CytomX Announce Strategic Research Collaboration in the Field of Conditional Bispecific Therapeutics for the Treatment of Cancer
    Regeneron and CytomX Announce Strategic Research Collaboration in the Field of Conditional Bispecific Therapeutics for the Treatment of Cancer PR Newswire
    26.09.22 - PR Newswire
    Thinking about buying stock in iSpecimen, Leslie's, Las Vegas Sands, Atlas Corp, or CytomX Therapeutics?
    Thinking about buying stock in iSpecimen, Leslie's, Las Vegas Sands, Atlas Corp, or CytomX Therapeutics? PR Newswire
    24.06.22 - PR Newswire
    Thinking about buying stock in Toughbuilt Industries, CytomX Therapeutics, Can Fite Biopharma, Hoth Therapeutics, or Bally's?
    Thinking about buying stock in Toughbuilt Industries, CytomX Therapeutics, Can Fite Biopharma, Hoth Therapeutics, or Bally's? PR Newswire
    23.03.21 - PR Newswire
    Thinking about buying stock in Ion Geophysical, OncoCyte, electroCore, CytomX Therapeutics, or Catalyst Biosciences?
    Thinking about buying stock in Ion Geophysical, OncoCyte, electroCore, CytomX Therapeutics, or Catalyst Biosciences? PR Newswire
    10.07.20 - PR Newswire
    ROSEN, A LONGSTANDING AND TOP RANKED FIRM, Reminds CytomX Therapeutics, Inc. Investors of Important Deadline in Securities Class Action - CTMX
    ROSEN, A LONGSTANDING AND TOP RANKED FIRM, Reminds CytomX Therapeutics, Inc. Investors of Important Deadline in Securities Class Action - CTMX PR Newswire
    07.07.20 - PR Newswire
    ROSEN, GLOBAL INVESTOR COUNSEL, Reminds CytomX Therapeutics, Inc. Investors of Important Deadline in Securities Class Action - CTMX
    ROSEN, GLOBAL INVESTOR COUNSEL, Reminds CytomX Therapeutics, Inc. Investors of Important Deadline in Securities Class Action - CTMX PR Newswire
    27.06.20 - PR Newswire
    LEAD PLAINTIFF DEADLINE: Johnson Fistel, LLP Encourages Investors to Contact the Firm
    LEAD PLAINTIFF DEADLINE: Johnson Fistel, LLP Encourages Investors to Contact the Firm PR Newswire
    22.06.20 - PR Newswire
    ROSEN, A LEADING NATIONAL FIRM, Reminds CytomX Therapeutics, Inc. Investors of Important July 20 Deadline in Securities Class Action - CTMX
    ROSEN, A LEADING NATIONAL FIRM, Reminds CytomX Therapeutics, Inc. Investors of Important July 20 Deadline in Securities Class Action - CTMX PR Newswire
    05.06.20 - PR Newswire
    ROSEN, TRUSTED NATIONAL TRIAL COUNSEL, Reminds CytomX Therapeutics, Inc. Investors of Important July 20 Deadline in Securities Class Action - CTMX
    ROSEN, TRUSTED NATIONAL TRIAL COUNSEL, Reminds CytomX Therapeutics, Inc. Investors of Important July 20 Deadline in Securities Class Action - CTMX PR Newswire
    04.06.20 - PR Newswire
    Moore Kuehn, PLLC Encourages Investors of CLNY, SRNE, and CTMX to Contact Law Firm
    Moore Kuehn, PLLC Encourages Investors of CLNY, SRNE, and CTMX to Contact Law Firm PR Newswire
    22.05.20 - PR Newswire
    CYTOMX LOSS ALERT, ROSEN, A TOP RANKED INVESTOR FIRM, Announces Filing of Securities Class Action Lawsuit Against CytomX Therapeutics, Inc.; Encourages Investors with Losses in Excess of $100K to Contact the Firm - CTMX
    CYTOMX LOSS ALERT, ROSEN, A TOP RANKED INVESTOR FIRM, Announces Filing of Securities Class Action Lawsuit Against CytomX Therapeutics, Inc.; Encourages Investors ...
    22.05.20 - PR Newswire
    CTMX Investor Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against CytomX Therapeutics, Inc. and Encourages Investors to Contact the Firm
    CTMX Investor Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against CytomX Therapeutics, Inc. and Encourages Investors to Contact the Firm PR ...
    03.10.17 - PR Newswire
    Amgen And CytomX Therapeutics Announce Strategic Collaboration In Immuno-Oncology
    Amgen And CytomX Therapeutics Announce Strategic Collaboration In Immuno-​Oncology Companies to Jointly Develop T-Cell Engaging Bispecific Probody PR Newswire
    21.09.17 - PR Newswire
    UNITY Biotechnology Appoints Additional Biotech Industry Veterans to Executive Team
    UNITY Biotechnology Appoints Additional Biotech Industry Veterans to Executive Team PR Newswire
    21.04.16 - PR Newswire
    AbbVie and CytomX Announce Strategic Collaboration for Probody Drug Conjugates
    AbbVie and CytomX Announce Strategic Collaboration for Probody Drug Conjugates - Companies to Jointly Develop and Commercialize Probody Drug Conjugates Directed Against ...

    Newssuche

    Videos

    newspaper
    30.04.24 -9,41%
    Technical Trading: Sojabohnen Long bis Juli
    Sojabohnen Long Typ: Turbo Open End WKN: VX41AH Hebel: 5 Laufzeit: OpenEnd Einstieg: Market ... Mehr »